Corporate Innovation reimagined.
We partner with fortune 2000 companies and governments along the innovation continuum, from innovation scouting to launching companies from scratch.
Corporate Innovation Continuum.
We identify startups that align with your innovation roadmap.
- Curated introductions to top founders from across the globe
- Invitations to startup innovation showcases
- Support structuring and implementing Pilots (POCs)
- Proprietary deal flow for investments
Discover new ways frontier tech can accelerate your business.
- Panel of leading experts at the forefront of AI/ML, AR/VR, Blockchain, and Robotics
- Demo innovative products that can open the business to new markets
- Using design thinking methodology, sponsor’s customers co-innovate solutions to vexing pain points
Identify an industry vertical or technology and leave the rest to us.
- Receive company and product information from dozens of high-growth startups globally
- Engage executives in the application review process, selecting cohorts of 10 startups
- Expose the business and technology to the cohort throughout the 4 month program
- Host a pitch night, introducing the startups to the broader community of partners and customers
Nex Cubed partners with fortune 500 companies to create startups from scratch.
- Create startups from scratch that either address pain points with no existing solution in the market or unlock latent IP that the company wishes to commercialize
- Our team of industry experts and serial entrepreneurs identify the market opportunity. The result is a business plan as well as a list of startups with relevant technologies
Our Services Leadership
Corporate Innovation at work.
Stay ahead of the innovation curve.
Contact us today to learn more about becoming a corporate innovation partner.
Companies we’ve created from scratch.
AuraNexus is a revolutionary, personalized, fully-interactive platform built to reignite personal connection, redevelop empathy amongst society, and revolutionize learning for the better.
Repurpose.AI is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.